drugset / Trial / NCT04096742
Altreno for Chest Rejuvenation
Phase 4
Unknown
40 enrolled
Goldman, Butterwick, Fitzpatrick and Groff
Bausch Health Americas, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a single-center, prospective, double-blind, randomized, vehicle-controlled study to evaluate the efficacy, safety and patient satisfaction of tretinoin 0.05% lotion (Altreno) for chest rejuvenation.
Timeline
- Start
- 2019-08-06
- Primary completion
- 2021-07-30
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tretinoin | Small molecule | 0.05 % | Topical |
Indications
No indication recorded.